CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Questionnaire and interviewWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D010300 Parkinsonian NIH 0.58

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients

The consequences of COVID-19 in these already fragile patients should be evaluated. It will be important to appreciate the confinement consequences imposed on the patient on the course and impact of the disease. These consequences can be assessed by the end of confinement and 6 months after the latter is lifted.

NCT04466839 Parkinson Disease COVID Other: Questionnaire and interview
MeSH:Parkinson Disease

Primary Outcomes

Description: To compare quality of life using Parkinson Disease Questionnaire-8 Items (PDQ-8 ), during the period of confinement linked to the Covid-19 pandemic and 6 months after the end of the pandemic in patients with idiopathic Parkinson's disease. The minimum value is "never" and maximum value is "always"

Measure: Impact of containment related to the Covid-19 pandemic.

Time: 6 months after the end of the pandemic

Secondary Outcomes

Description: Describe in a cohort of Parkinson's patients the conditions of confinement during the confinement period linked to the Covid-19 pandemic such as lifestyle (patient living alone, patient living with a caregiver, patient living in nursing home) and continuing paramedical care (physiotherapist, speech therapist), thanks to a psychosocial assessment

Measure: Conditions of containment during the Covid-19 pandemic.

Time: Day 1

Description: Infected patients will be defined as having had a positive polymerase chain reaction (PCR) or compatible chest scanner. Patients potentially infected: patients who presented symptoms during the period which could suggest an infection by the Covid-19 virus: cough, fever and dyspnea

Measure: The number of patients infected or possibly infected with Covid-19

Time: 6 months after the end of the pandemic

Description: Patients will be asked to list the 3 main symptoms that have changed during the confinement period

Measure: Symptoms modifications

Time: 6 months after the end of the pandemic


No related HPO nodes (Using clinical trials)